HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive monitoring of renal blood flow characteristics during acute renal failure in man.

Abstract
Duplex Doppler ultrasound (DDU) was used to study the blood flow characteristics of the renal interlobar artery in 20 subjects with acute renal failure (ARF), 14 subjects with transient impairment of renal function and 23 control subjects with normal function. Renovascular resistance was assessed by pulsatility index (PI) and change in flow velocity by change in mean frequency shift (delta f). The 99% confidence intervals for PI in the three groups were 3.32-5.46, 1.58-2.34 and 0.99-1.33 respectively. Values for delta f were 0.2-0.38, 0.5-0.62 and 0.7-1.02 kHz respectively. Ten ARF patients recovered function, 99% confidence intervals for PI just prior to recovery were 0.9-1.48 and for delta f 0.52-1.02 kHz. There was increased renovascular resistance and reduced intrarenal blood flow velocity at the onset of ARF. These changes persisted during ARF; recovery of function occurred after they returned to normal. Similar, but less marked, changes were found in patients with a transient impairment of function.
AuthorsP E Stevens, S J Gwyther, M E Hanson, J E Boultbee, W J Kox, M E Phillips
JournalIntensive care medicine (Intensive Care Med) Vol. 16 Issue 3 Pg. 153-8 ( 1990) ISSN: 0342-4642 [Print] United States
PMID2191017 (Publication Type: Case Reports, Journal Article)
Topics
  • Acute Kidney Injury (etiology, pathology, physiopathology)
  • Aged
  • Blood Flow Velocity
  • Blood Pressure
  • Humans
  • Male
  • Monitoring, Physiologic (instrumentation, methods)
  • Necrosis
  • Pulsatile Flow
  • Renal Circulation
  • Ultrasonography
  • Vascular Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: